Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,006 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

for
Healthy Volunteer
Location: Maitland FL, Miami FL, Marlton NJ, Grayslake IL
Sponsor: AbbVie

Sex: All

Age: 65 - 70+

Code: NCT07219030

Phase1, Recruiting
FeaturedNew

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Orlando FL, Kissimmee FL, New Port Richey FL, Miami FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase2, Recruiting
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Orlando FL, Port Orange FL, Lakeland FL, Tampa FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase3, Recruiting
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: Orlando FL, Nashville TX, Chicago IL, New Haven CT,
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT05800665

Phase1, Recruiting
Featured

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Kissimmee FL, Monroe NC, Fresh Meadows NY, Chicago IL,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06979336

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

for
Systemic Lupus Erythematosus, Rheumatoid Arthritis
Location: Kissimmee FL, Tampa FL, Clearwater FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07607964

Phase1, Recruiting
Featured

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: Lake Mary FL, Winter Haven FL, Fort Myers FL,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase3, Recruiting
Featured

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Kissimmee FL, Dothan AL, Birmingham AL, Richmond VA,
Sponsor: AbbVie

Sex: All

Age: 40+

Code: NCT07230288

Phase2, Recruiting
Featured

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

for
Non Small Cell Lung Carcinoma
Location: Orange City FL, Jacksonville FL, Leesburg VA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06772623

Phase1, Phase2, Recruiting
Featured

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: Winter Haven FL, Athens GA, Lexington KY, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06236438

Phase2, Phase3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Rockledge FL, Tampa FL, Jacksonville FL, Knoxville TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155187

Phase2, Phase3, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Port Orange FL, Clearwater FL, St. Petersburg FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase3, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Orlando FL, Winter Park FL, DeLand FL, Viera FL,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07231419

Phase3, Recruiting
Active & Responsive

An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

for
Post Traumatic Stress Disorder
Location: Orlando FL, Maitland FL, Jacksonville FL, Lauderhill FL,
Sponsor: Transcend Therapeutics

Sex: All

Age: 18+

Code: NCT07456696

Phase3, Recruiting
Active & Responsive

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

for
Obesity
Location: Orlando FL, Miramar FL, Charleston SC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07339423

Phase3, Recruiting
Active & Responsive

DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

for
Obstructive Sleep Apnea (OSA)
Location: Orlando FL, Brandon FL, West Palm Beach FL, Anderson SC,
Sponsor: Incannex Healthcare Ltd

Sex: All

Age: 18 - 65

Code: NCT07635563

Phase2, Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Orlando FL, Nashville TN, Fairfax VA, Indianapolis IN,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Orlando FL, Tampa FL, Coral Springs FL, Nashville TN,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase1, Recruiting
Active & Responsive

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

for
Solid Tumors (Phase 1), RAS Mutation
Location: Orlando FL, Houston TX
Sponsor: Adlai Nortye Biopharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07252479

Phase1, Recruiting
Active & Responsive

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

for
Advanced Solid Cancers
Location: Orlando FL, New York NY, Denver CO
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07186842

Phase1, Phase2, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando